Skip to main content

Catherine Sazdanoff, John McIlwraith

Catherine Sazdanoff and John McIlwraith have been elected independent directors to Meridian Biosciences' board, effective Aug. 14. 

Sazdanoff is the CEO and president of Sazdanoff Consulting. Between 2006 and 2015, she held various executive positions at Takeda Pharmaceutical International, including vice president, head of corporate projects; VP global business development; and VP corporate development. Prior to Takeda, Sazdanoff spent 22 years at Abbott Laboratories. 

McIlwraith co-founded venture capital firm Allos Ventures in 2010 and has been a managing director there since then. Prior to that, he was a managing director at Blue Chip Venture. He currently is the lead director at Assurex Health. 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.